| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. | Director | Stock Option (right to buy) | 27,000 | 12 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HOWL | Werewolf Therapeutics, Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:10 |
| HOWL | Werewolf Therapeutics, Inc. | 24 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 19:44 |
| HOWL | Werewolf Therapeutics, Inc. | 21 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:52 |
| HOWL | Werewolf Therapeutics, Inc. | 01 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 16:39 |